Scientists receive £2.8 million funding boost to advance research into low-grade brain tumors
Grant and Award Announcement
Updates every hour. Last Updated: 16-Dec-2025 21:11 ET (17-Dec-2025 02:11 GMT/UTC)
The Brain Tumour Research Centre of Excellence at the University of Plymouth is a hub for world-leading research into low-grade tumours including low-grade glioma, meningioma, and schwannoma. Renewed funding from the charity Brain Tumour Research will enable scientists to deepen their understanding of how these tumours develop and translate that knowledge into life-changing therapies.
Breast cancer is able to modify the lymphatic vessels through which it travels to the draining lymph nodes. From there, it can then spread to other parts of the body. A new finding by Finnish researchers may help develop targeted therapies that could prevent this spread.
For many people living with cancer, symptoms such as pain, anxiety or insomnia can quickly spiral into an emergency room visit. Such visits can be financially costly and take an emotional toll on patients and their caregivers. A new study led by Mayo Clinic researchers found that using digital check-ins and a remote care team can help patients manage symptoms before they reach a crisis point.
Researchers examined five AI models on multiple genomic tasks to see how well they performed
Models performed well overall, with each having strengths and weaknesses based on the desired task
Study provides a framework for researchers to choose optimal AI models for specific genomic tasks
Researchers from Mass General Brigham Cancer Institute will present research discoveries and outcomes from clinical trials in hematology/oncology, including cancer and common blood disorders, at the 2025 American Society of Hematology (ASH) annual meeting, held December 6-9, in Orlando.
A new analysis of research into the most common type of breast cancer has zeroed in on an overlooked hormone that may be responsible for the increased risk of breast cancer death in post-menopausal women with obesity. It also raises the possibility that treatment of these aggressive breast cancers could be improved with addition of weight-loss drugs known as GLP-1 receptor agonists.